Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US.
New Enterprise Associates led the oversubscribed financing round, which was also backed by current investors such as Echo Health Ventures, Max Ventures, AlleyCorp and Intermountain Ventures.
Go deeper with GlobalData
Since its Series A financing, the physician-led approach of the company has resulted in a 91.6% rate of clinically significant pain improvement among individuals, a 78% to 90% decrease in elective orthopaedic surgeries and a 42% reduction in opioid usage.
Vori Health has noted an up-to-68% decrease in anxiety and depression in some individuals.
The approach has delivered a verified 4:1 return on investment (ROI) while maintaining the satisfaction of the patient. Its approach integrates board-certified physicians, health coaches, physical therapists and registered dietitians.
Vori Health plans to deepen its value-based care initiatives, including moving towards sophisticated economic models with two-sided population health risk.
The company also seeks to invest in data analytics, target high-risk members and improve AI-powered technology platforms and clinical programmes, benefitting employers, health plan partners and patients.
Vori Health was founded by Yale and Mayo Clinic surgeons and provides patients with a recovery pathway that optimises outcomes, decreases needless interventions and supports the overall care experience.
Vori Health CEO and co-founder Dr Ryan Grant stated: “This investment marks a pivotal moment in our journey to deliver truly value-based musculoskeletal care at scale.
“By integrating board-certified speciality physicians, cohesive care teams and cutting-edge technology, we’re achieving outstanding outcomes nationwide.”
